Navigation Links
Longs Reports Preliminary March Retail Drug Store Sales
Date:4/10/2008

WALNUT CREEK, Calif., April 10 /PRNewswire-FirstCall/ -- Longs Drug Stores Corporation (NYSE: LDG) today reported preliminary total retail drug store sales for the five-week and nine-week periods ended April 3, 2008.

Periods ended April 3, 2008

Month Quarter to Date

(Dollars in millions) (5 weeks) (9 weeks)

Total retail drug store sales $474 $853

Increase from comparable prior year

period 4.7% 4.0%

Same-store sales increase:

Pharmacy 0.1% 1.0%

Front-end 5.7% 3.2%

Total 2.8% 2.1%

Longs estimated that preliminary March front-end same-store sales were favorably impacted by approximately 350 to 400 basis points as a result of the three-week shift in Easter holiday sales. Easter occurred on March 23 this year versus April 18 last year.

Longs estimated that preliminary March pharmacy same-store sales were unfavorably impacted by approximately 525 to 575 basis points as a result of recent generic introductions being substituted for higher-priced brand name drugs. In addition, the switch of the prescription allergy medicine Zyrtec to over-the-counter status and a mild conclusion to the cold and flu season versus last year had an unfavorable impact of approximately 125 to 150 basis points on pharmacy same-store sales.

About the Company

Headquartered in Walnut Creek, California, Longs Drug Stores Corporation (NYSE: LDG) is one of the most recognized retail drug store chains on the West Coast and in Hawaii. The Company operates 512 retail pharmacies and offers a wide assortment of merchandise focusing on health, wellness, beauty and convenience. Longs also provides pharmacy benefit management services and Medicare beneficiary prescription drug plans through its wholly-owned subsidiary, RxAmerica, LLC. Additional information about Longs and its services is available at http://www.longs.com and more information about RxAmerica is available at http://www.rxamerica.com.

Contact: 925-979-3979


'/>"/>
SOURCE Longs Drug Stores Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Longs Drugs Announces Immunization Program for the 2007/2008 Flu Season
2. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
3. Longs Drugs Plans to Become the First Retailer in Hawaii With Walk-in Medical Clinics
4. Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
5. Treating oft ignored non-cancer health issues after cancer diagnosis prolongs survival
6. Longs Drug Stores Corporation Declares Cash Dividend on Common Shares
7. Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008
8. Longs Reports Preliminary February Retail Drug Store Sales
9. Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer
10. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
11. Haemacure Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: